Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 601–700 of 1,128
Nuclear localization sequence of FUS and induction of stress granules by ALS mutants
Gal, J., Zhang, J., Kwinter, D. M., Zhai, J., Jia, H., Jia, J., & Zhu, H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.06.010 · Cited by 215
“Mutations in Cu/Zn superoxide dismutase (SOD1) were first discovered (Rosen et al., 1993), which account for about 20% of the familial cases.”
BackgroundMotor Neuron Susceptibility in ALS/FTD
Ragagnin, A. M. G., Shadfar, S., Vidal, M., Jamali, M. S., & Atkin, J. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00532 · Cited by 214
Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis
Kwak, S., & Kawahara, Y. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0599-z · Cited by 215
Rouaux, C., Panteleeva, I., René, F., Gonzalez de Aguilar, J.-L., Echaniz-Laguna, A., Dupuis, L., Menger, Y., Boutillier, A.-L., & Loeffler, J.-P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1139-07.2007 · Cited by 213
“Sodium Valproate Exerts Neuroprotective Effects In Vivo through CREB-Binding Protein-Dependent Mechanisms But”
BackgroundMutation of SOD1 in ALS: a gain of a loss of function
Sau, D., De Biasi, S., Vitellaro-Zuccarello, L., Riso, P., Guarnieri, S., Porrini, M., Simeoni, S., Crippa, V., Onesto, E., Palazzolo, I., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm110 · Cited by 212
“To this end, we have: (1) analyzed in vivo the cellular distribution of SOD1 in transgenic mice expressing either wild-type (wt) or mutant G93A-SOD1; we then further analyzed in vitro, in immortalized motoneuronal NSC34 cells, the effects of the G93A-SOD1 mutation (2) on the cytoplasmic and nuclear SOD1 distribution,…”
BackgroundMitne-Neto, M., Machado-Costa, M., Marchetto, M. C. N., Bengtson, M. H., Joazeiro, C. A., Tsuda, H., Bellen, H. J., Silva, H. C. A., Oliveira, A. S. B., Lazar, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr284 · Cited by 214
“been implicated in ALS, including superoxide dismutase 1 (SOD1, ALS1) (5), Tar-DNA-binding protein-43 (TDP-43, ALS10) (6–8), fused sarcoma (FUS, ALS6) (9,10) and vamp-associated protein B/C (VAPB, ALS8) (11).”
InfluentialLiu, Y., Wolstenholme, C. H., Carter, G. C., Liu, H., Hu, H., Grainger, L. S., Miao, K., Fares, M., Hoelzel, C. A., Yennawar, H. P., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02176 · Cited by 211
Papadeas, S. T., Kraig, S. E., O'Banion, C., Lepore, A. C., & Maragakis, N. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103141108 · Cited by 213
“Although most ALS cases are sporadic, 5–10% are inherited, with 20% of those cases linked to dominant mutations in the gene encoding for Cu/Zn superoxide dismutase 1 (SOD1) (2).”
BackgroundTradewell, M. L., Yu, Z., Tibshirani, M., Boulanger, M.-C., Durham, H. D., & Richard, S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr448 · Cited by 212
“The first gene to be linked to ALS (ALS1) was SOD1 (encoding Cu/Zn-superoxide dismutase) and its mutations account for 20% of FALS cases (4).”
Inflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. E.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 212
“Less than 20% of ALS cases are familial associated with missense mutation in SOD1 (Rosen, 1993; Gros-Louis et al., 2006).”
BackgroundProteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis
Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V., Lacomis, D., Urbinelli, L., Newhall, K., Cudkowicz, M. E., Brown, R. H., & Bowser, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03478.x · Cited by 212
“In ALS, changes in protein composition of the cerebrospinal fluid (CSF) or serum may denote corresponding alterations in protein expression, post-translational modifications or turn-over within the tissue of the central nervous system (CNS) ( Rohlff 2000 ).”
BackgroundSelf-citationMalaspina, A., Kaushik, N., & De Belleroche, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00231.x · Cited by 212
Sancar, A. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.000441 · Cited by 212
Protective effects and mechanisms of sirtuins in the nervous system
Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., & Chen, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.001 · Cited by 211
Bcl-2 family regulation of neuronal development and neurodegeneration
Akhtar, R. S., Ness, J. M., & Roth, K. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.013 · Cited by 210
van Es, M. A., Van Vught, P. W., Blauw, H. M., Franke, L., Saris, C. G., Andersen, P. M., Van Den Bosch, L., de Jong, S. W., van 't Slot, R., Birve, A., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70222-3 · Cited by 210
From structure to redox: The diverse functional roles of disulfides and implications in disease
Bechtel, T. J., & Weerapana, E. (2017) · PROTEOMICS · doi:10.1002/pmic.201600391 · Cited by 211
Cunha-Oliveira, T., Montezinho, L., Mendes, C., Firuzi, O., Saso, L., Oliveira, P. J., & Silva, F. S. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5021694 · Cited by 206
Couillard-Després, S., Zhu, Q., Wong, P. C., Price, D. L., Cleveland, D. W., & Julien, J.-P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9626 · Cited by 210
Ben Hamida, C., Doerflinger, N., Belal, S., Linder, C., Reutenauer, L., Dib, C., Gyapay, G., Vignal, A., Le Paslier, D., Cohen, D., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-195 · Cited by 212
Moisse, K., Volkening, K., Leystra-Lantz, C., Welch, I., Hill, T., & Strong, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.021 · Cited by 210
“All rights reserved protein (TDP-43) aggregation, progranulin (PGRN) mutations, aberrant inflammatory processes, and protein aggregation (Arai et al., 2006; Moisse and Strong, 2006; Strong, 1999; Neumann et al., 2006; Rosen et al., 1993; Strong et al., 2005; Eriksen and Mackenzie, 2008).”
BackgroundA Yeast Model of FUS/TLS-Dependent Cytotoxicity
Ju, S., Tardiff, D. F., Han, H., Divya, K., Zhong, Q., Maquat, L. E., Bosco, D. A., Hayward, L. J., Brown, R. H., Lindquist, S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001052 · Cited by 207
“More than 150 different ALS mutations, spanning virtually the entire coding sequence of the highly conserved SOD1 gene, have been identified—nearly all of them exhibiting autosomal dominant inheritance [1].”
BackgroundSelf-citationMitochondrial involvement in amyotrophic lateral sclerosis
Menzies, F. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00125-5 · Cited by 210
Neurotrophins and neurodegeneration
Dawbarn, D., & Allen, S. J. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00487.x · Cited by 210
A General Strategy to Control Viscosity Sensitivity of Molecular Rotor‐Based Fluorophores
Ye, S., Zhang, H., Fei, J., Wolstenholme, C. H., & Zhang, X. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202011108 · Cited by 207
Carrı̀, M. T., Ferri, A., Cozzolino, M., Calabrese, L., & Rotilio, G. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00179-5 · Cited by 209
Structural Models of Amyloid‐Like Fibrils
Nelson, R., & Eisenberg, D. (2006) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(06)73008-x · Cited by 207
Dorfin Ubiquitylates Mutant SOD1 and Prevents Mutant SOD1-mediated Neurotoxicity
Niwa, J.-I., Ishigaki, S., Hishikawa, N., Yamamoto, M., Doyu, M., Murata, S., Tanaka, K., Taniguchi, N., & Sobue, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206559200 · Cited by 209
Human TBK1: A Gatekeeper of Neuroinflammation
Ahmad, L., Zhang, S.-Y., Casanova, J.-L., & Sancho-Shimizu, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.006 · Cited by 208
Mitochondrial dysfunction, oxidative stress and neurodegeneration
Mancuso, M., Coppede, F., Migliore, L., Siciliano, G., & Murri, L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10110 · Cited by 208
“20% of fALS cases are due to mutations in the gene encoding for the SOD1 [127].”
Sporadic and hereditary amyotrophic lateral sclerosis (ALS)
Ajroud-Driss, S., & Siddique, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.010 · Cited by 207
Self-citationThe Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
Loeffler, J., Picchiarelli, G., Dupuis, L., & Gonzalez De Aguilar, J. (2016) · Brain Pathology · doi:10.1111/bpa.12350 · Cited by 206
“Mutations in SOD1, which encodes the free radical-scavenging enzyme Cu/Zn superoxide dismutase, account for 20% of familial cases and 2%–7% of sporadic cases (96, 100).”
BackgroundFurukawa, Y., Kaneko, K., Yamanaka, K., O'Halloran, T. V., & Nukina, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802083200 · Cited by 207
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis
Corrado, L., Ratti, A., Gellera, C., Buratti, E., Castellotti, B., Carlomagno, Y., Ticozzi, N., Mazzini, L., Testa, L., Taroni, F., et al. (2009) · Human Mutation · doi:10.1002/humu.20950 · Cited by 207
“Mutations in the Cu/Zn superoxide dismutase 1 (SOD1; MIM 147450) gene are detected in 20% of FALS and 1% of sporadic ALS (SALS) cases [Pasinelli and Brown, 2006; Rosen et al., 1993].”
BackgroundCCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
Williams, K. L., Topp, S., Yang, S., Smith, B., Fifita, J. A., Warraich, S. T., Zhang, K. Y., Farrawell, N., Vance, C., Hu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11253 · Cited by 206
Self-citationGenetics of amyotrophic lateral sclerosis
Siddique, T., & Deng, H.-X. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1465 · Cited by 206
Self-citationWang, J., Farr, G. W., Hall, D. H., Li, F., Furtak, K., Dreier, L., & Horwich, A. L. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000350 · Cited by 206
“We report on effects of an ALS-associated, misfolding-prone mutant human SOD1, G85R, when expressed in the neurons of Caenorhabditis elegans.”
BackgroundInfluentialResveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Mancuso, R., del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., Ramirez-Núñez, O., Pallás, M., Portero-Otin, M., Osta, R., & Navarro, X. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0253-y · Cited by 206
“Among these, mutations in the gene encoding for the enzyme Cu/Zn superoxide dismutase 1 (SOD1) are observed in about 20% of the patients [2].”
The Pathobiology of Amyotrophic Lateral Sclerosis: A Proteinopathy?
Strong, M. J., Kesavapany, S., & Pant, H. C. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000173889.71434.ea · Cited by 206
“The most common gene defect in familial ALS is a mutation in the copper/zinc superoxide dismutase gene (SOD1) at 21q22 (ALS1) (34).”
BackgroundCellular Proteostasis in Neurodegeneration
Kurtishi, A., Rosen, B., Patil, K. S., Alves, G. W., & Møller, S. G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1334-z · Cited by 205
Genetic testing and risk assessment for spinal muscular atrophy (SMA)
Ogino, S., & Wilson, R. (2002) · Human Genetics · doi:10.1007/s00439-002-0828-x · Cited by 205
Peroxynitrite: reactive, invasive and enigmatic
Groves, J. T. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80036-2 · Cited by 206
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
Bradley, W. G., & Mash, D. C. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903286009 · Cited by 205
Ito, H., Wate, R., Zhang, J., Ohnishi, S., Kaneko, S., Ito, H., Nakano, S., & Kusaka, H. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.017 · Cited by 203
ALS Mutants of Human Superoxide Dismutase Form Fibrous Aggregates Via Framework Destabilization
DiDonato, M., Craig, L., Huff, M. E., Thayer, M. M., Cardoso, R. M. F., Kassmann, C. J., Lo, T. P., Bruns, C. K., Powers, E. T., Kelly, J. W., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00889-1 · Cited by 203
Mitochondrial dysfunction in amyotrophic lateral sclerosis
Shi, P., Gal, J., Kwinter, D. M., Liu, X., & Zhu, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.012 · Cited by 205
“Among the familial cases, the most common disease-causing mutations are found in the copper-zinc superoxide dismutase (SOD1) gene [1,2].”
BackgroundFoust, K. D., Salazar, D. L., Likhite, S., Ferraiuolo, L., Ditsworth, D., Ilieva, H., Meyer, K., Schmelzer, L., Braun, L., Cleveland, D. W., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.211 · Cited by 204
Altintas, O., Park, S., & Lee, S.-J. V. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.2.261 · Cited by 204
Bonafede, R., & Mariotti, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00080 · Cited by 204
“The protein contains one copper and one zinc atom: the first is fundamental for SOD1 activity, while zinc plays a role in the structural stability of the enzyme (Rosen et al., 1993).”
BackgroundiPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Okano, H., & Morimoto, S. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.01.007 · Cited by 202
Diseases related to oxygen-derived free radicals.
Knight, J. A. (1995) · PubMed · Cited by 229
DNA damage in neurodegenerative diseases
Coppedè, F., & Migliore, L. (2015) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2014.11.010 · Cited by 204
A Frameshift Deletion in Peripherin Gene Associated with Amyotrophic Lateral Sclerosis
Gros-Louis, F., Larivière, R., Gowing, G., Laurent, S., Camu, W., Bouchard, J.-P., Meininger, V., Rouleau, G. A., & Julien, J.-P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408139200 · Cited by 204
Self-citationFerraiuolo, L., Higginbottom, A., Heath, P. R., Barber, S., Greenald, D., Kirby, J., & Shaw, P. J. (2011) · Brain · doi:10.1093/brain/awr193 · Cited by 203
“Approximately 5% of cases with ALS are familial, and 20% of these have been linked to mutations in Cu/Zn superoxide dismutase 1 (SOD1) (Rosen et al., 1993).”
BackgroundZebrafish models in neuropsychopharmacology and CNS drug discovery
Khan, K. M., Collier, A. D., Meshalkina, D. A., Kysil, E. V., Khatsko, S. L., Kolesnikova, T., Morzherin, Y. Y., Warnick, J. E., Kalueff, A. V., & Echevarria, D. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13754 · Cited by 204
“Nevertheless, SOD1 is the most well-understood gene to be associated with ALS (Rosen et al., 1993), and mutations in the SOD1 gene account for 20% of familial ALS cases (Valdmanis and Rouleau, 2008).”
BackgroundModelling amyotrophic lateral sclerosis: progress and possibilities
Van Damme, P., Robberecht, W., & Van Den Bosch, L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029058 · Cited by 204
“The discovery of mutations in SOD1 in 1993 heralded the era of ALS disease modelling (Rosen et al., 1993).”
TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS
Zuo, X., Zhou, J., Li, Y., Wu, K., Chen, Z., Luo, Z., Zhang, X., Liang, Y., Esteban, M. A., Zhou, Y., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-00537-7 · Cited by 203
Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35
Hentati, A., Bejaoui, K., Pericak-Vance, M. A., Hentati, F., Speer, M. C., Hung, W.-Y., Figlewicz, D. A., Haines, J., Rimmler, J., Ben Hamida, C., et al. (1994) · Nature Genetics · doi:10.1038/ng0794-425 · Cited by 205
Self-citationTakuma, H., Kwak, S., Yoshizawa, T., & Kanazawa, I. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<806::aid-ana2>3.0.co;2-s · Cited by 234
Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis
Sargsyan, S. A., Monk, P. N., & Shaw, P. J. (2005) · Glia · doi:10.1002/glia.20210 · Cited by 203
“ALS is a familial disease in 5–10% of cases and most insights into disease pathogenesis have come from the study of the effects of Cu/Zn superoxide dismutase-1 (SOD1) mutations, which account for 20% of familial cases (Andersen, 2003; Rosen et al., 1993).”
BackgroundA randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
Cudkowicz, M. E., Shefner, J. M., Schoenfeld, D. A., Brown Jr., R. H., Johnson, H., Qureshi, M., Jacobs, M., Rothstein, J. D., Appel, S. H., Pascuzzi, R. M., et al. (2003) · Neurology · doi:10.1212/wnl.61.4.456 · Cited by 203
Neurotrophic and Neuroregenerative Effects of GH/IGF1
Bianchi, V., Locatelli, V., & Rizzi, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112441 · Cited by 202
“These data demonstrated a correlation between GH deficiency and hSOD1(G93A) expression, and are essential for the consideration of GH and IGF-1 therapy in ALS.”
BackgroundInfluentialImpairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease
Chandrasekaran, K., Giordano, T., Brady, D. R., Stoll, J., Martin, L. J., & Rapoport, S. I. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90147-3 · Cited by 202
Jung, C., Higgins, C. M. J., & Xu, Z. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01112.x · Cited by 202
Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations
Bäumer, D., Hilton, D., Paine, S. M. L., Turner, M. R., Lowe, J., Talbot, K., & Ansorge, O. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ed9cde · Cited by 202
Shinder, G. A., Lacourse, M.-C., Minotti, S., & Durham, H. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010759200 · Cited by 202
Roberts, B. R., Lim, N. K. H., McAllum, E. J., Donnelly, P. S., Hare, D. J., Doble, P. A., Turner, B. J., Price, K. A., Chun Lim, S., Paterson, B. M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4196-13.2014 · Cited by 200
“Over 100 different SOD1 mutations account for 20% of familial ALS cases (Rosen et al., 1993), and SOD1 mutations are also present in sporadic forms of the disease (Andersen et al.”
BackgroundKlivenyi, P., Kiaei, M., Gardian, G., Calingasan, N. Y., & Beal, M. F. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02160.x · Cited by 200
Cancer as a mitochondrial metabolic disease
Seyfried, T. N. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00043 · Cited by 198
“Replacement of dysfunctional mitochondria with normal mitochondria will restore normal energy homeostasis and the differentiated state.”
BackgroundDupuis, L., & Loeffler, J.-P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.03.007 · Cited by 200
The neurobiology of sirtuins and their role in neurodegeneration
Donmez, G. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.05.007 · Cited by 200
Forsberg, K., Andersen, P. M., Marklund, S. L., & Brännström, T. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0805-3 · Cited by 199
“More than 150 mutations in the ubiquitously expressed enzyme superoxide dismutase-1 (SOD1) have been associated with familial ALS (FALS) and such mutations are found in about 6% of all ALS patients [35, 45] (http://alsod.”
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS
Kirby, J., Halligan, E., Baptista, M. J., Allen, S., Heath, P. R., Holden, H., Barber, S. C., Loynes, C. A., Wood-Allum, C. A., Lunec, J., et al. (2005) · Brain · doi:10.1093/brain/awh503 · Cited by 200
“Mutations in SOD1 were identified as causative for ALS in 1993 (Rosen et al., 1993), and although there is substantial evidence that motor neuron degeneration occurs through a toxic gain of function of the mutant Cu/Zn SOD protein, the underlying pathophysiological mechanism is still unknown.”
BackgroundTransgenic Rat Model of Neurodegeneration Caused by Mutation in the TDP Gene
Zhou, H., Huang, C., Chen, H., Wang, D., Landel, C. P., Xia, P. Y., Bowser, R., Liu, Y.-J., & Xia, X. G. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000887 · Cited by 200
“Typical ALS has a late onset and rapidly progresses [12,13,17,29,49–51].”
BackgroundFerraiuolo, L., Heath, P. R., Holden, H., Kasher, P., Kirby, J., & Shaw, P. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1470-07.2007 · Cited by 199
“Approximately 10% of cases are familial, and 20% of these have been linked to a dominant mutant form of the Cu/Zn superoxide dismutase 1 (SOD1) enzyme (Rosen et al., 1993).”
BackgroundKiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N. Y., & Beal, M. F. (2005) · Neurodegenerative Diseases · doi:10.1159/000090364 · Cited by 199
Wang, Q., Johnson, J. L., Agar, N. Y. R., & Agar, J. N. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060170 · Cited by 198
“One of these genes encoding Cu/Znsuperoxide dismutase (SOD1) was found to associate with 20% of fALS, and at least 119 fALS-associated SOD1 mutations have been characterized in humans [1,5].”
BackgroundLIU, D., WEN, J., LIU, J., & LI, L. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2318 · Cited by 197
“patients (2, 3) linked this disease to free radicals (4).”
BackgroundAdaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
Banerjee, R., Mosley, R. L., Reynolds, A. D., Dhar, A., Jackson-Lewis, V., Gordon, P. H., Przedborski, S., & Gendelman, H. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002740 · Cited by 198
“(SOD1) [3] recapitulate ALS pathobiology including neuroin-”
The elusive transporters with a high affinity for glutamate
Kanai, Y., Smith, C. P., & Hediger, M. A. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90094-3 · Cited by 198
Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis
Miyazaki, K., Ohta, Y., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22594 · Cited by 197
“About 15–20% of FALS cases are associated with missense mutations or small deletions in the gene that encodes Cu/ Zn-superoxide dismutase 1 (SOD1; Aoki et al., 1993; Rosen et al., 1993).”
BackgroundSun, S., Sun, Y., Ling, S.-C., Ferraiuolo, L., McAlonis-Downes, M., Zou, Y., Drenner, K., Wang, Y., Ditsworth, D., Tokunaga, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520639112 · Cited by 196
“Proc Natl Acad Sci USA 111(2):829–832.”
BackgroundInfluentialA Role for Superoxide in Protein Kinase C Activation and Induction of Long-term Potentiation
Klann, E., Roberson, E. D., Knapp, L. T., & Sweatt, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4516 · Cited by 197
Tong, J., Huang, C., Bi, F., Wu, Q., Huang, B., Liu, X., Li, F., Zhou, H., & Xia, X. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.122 · Cited by 195
“…mutations of individual genes such as superoxide dismutase 1 ( SOD1 ), Tar DNA-binding protein 43 ( TDP-43 ), and C9ORF72 (Deng et al , 1993, 2011; Rosen et al , 1993; Gurney et al , 1994; Kabashi et al , 2008a, b; Rutherford et al , 2008; Sreedharan et al , 2008; Van Deerlin et al , 2008;…”
The role of the cellular antioxidant defense in oxidant carcinogenesis.
Cerutti, P., Ghosh, R., Oya, Y., & Amstad, P. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s10123 · Cited by 193
Viader, A., Golden, J. P., Baloh, R. H., Schmidt, R. E., Hunter, D. A., & Milbrandt, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0884-11.2011 · Cited by 193
“This is best exemplified by amyotrophic lateral sclerosis (ALS), a disease characterized by premature death of motor neurons that is sometimes linked to dominant mutations in the antioxidant protein superoxide dismutase 1 (SOD1) (Rosen et al., 1993).”
BackgroundBaker, A., Kalmbach, B., Morishima, M., Kim, J., Juavinett, A., Li, N., & Dembrow, N. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0150-18.2018 · Cited by 196
“In a mouse model of SOD1-ALS, corticospinal motor neurons, a subtype of L5B PT neuron of the motor cortex, selectively degenerates (Rosen et al., 1993; Gurney et al., 1994; Özdinler et al., 2011; Jara et al., 2012; Fogarty et al., 2016a, b, 2017; Saba et al., 2016).”
BackgroundSuperoxide dismutase and the death of motoneurons in ALS
Beckman, J. S., Estévez, A. G., Crow, J. P., & Barbeito, L. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01981-0 · Cited by 196
Aluminium and the risk for alzheimer's disease
McLachlan, D. R. C. (1995) · Environmetrics · doi:10.1002/env.3170060303 · Cited by 195
Wang, J., Xu, G., & Borchelt, D. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0471 · Cited by 196
Amstad, P., Moret, R., & Cerutti, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42068-0 · Cited by 196
Bendotti, C., Tortarolo, M., Suchak, S. K., Calvaresi, N., Carvelli, L., Bastone, A., Rizzi, M., Rattray, M., & Mennini, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00572.x · Cited by 195
The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum
van Langenhove, T., van der Zee, J., & van Broeckhoven, C. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.665471 · Cited by 195
Corti, S., Locatelli, F., Donadoni, C., Guglieri, M., Papadimitriou, D., Strazzer, S., Del Bo, R., & Comi, G. P. (2004) · Brain · doi:10.1093/brain/awh273 · Cited by 195
“About 10% of cases are dominantly inherited and 20% of these arise from mutations in the gene for Cu/Zn superoxide dismutase (SOD1) (Rosen, 1993).”
BackgroundA genome-wide association study of sporadic ALS in a homogenous Irish population
Cronin, S., Berger, S., Ding, J., Schymick, J. C., Washecka, N., Hernandez, D. G., Greenway, M. J., Bradley, D. G., Traynor, B. J., & Hardiman, O. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm361 · Cited by 195
The superoxide radical switch in the biology of nitric oxide and peroxynitrite
Piacenza, L., Zeida, A., Trujillo, M., & Radi, R. (2022) · Physiological Reviews · doi:10.1152/physrev.00005.2022 · Cited by 190
Mild ALS in Japan associated with novel SOD mutation
Ogasawara, M., Matsubara, Y., Narisawa, K., Aoki, M., Nakamura, S., Itoyama, Y., & Abe, K. (1993) · Nature Genetics · doi:10.1038/ng1293-323 · Cited by 195
Tashiro, Y., Urushitani, M., Inoue, H., Koike, M., Uchiyama, Y., Komatsu, M., Tanaka, K., Yamazaki, M., Abe, M., Misawa, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417600 · Cited by 194
“Conversely, there is a report showing that dietary restriction, but not rapamycin (an autophagy inducer), ameliorates the symptoms of mutant SOD1 transgenic mice (33) Therefore, the predominant involvement of autophagy in ALS pathogenesis is a matter of debate, This is in part due to the complex effects of pharmacolog…”
BackgroundMethodInfluentialFocal degeneration of astrocytes in amyotrophic lateral sclerosis
Rossi, D., Brambilla, L., Valori, C. F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D. E., & Volterra, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.99 · Cited by 194
“In about 1–2% of patients, the disease is linked to mutations in the gene coding for Cu-Zn superoxide dismutase (SOD1).(1) Transgenic animals that overexpress mutant human SOD1s (hSOD1s) develop progressive ALS-like disease.”
Background
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.